2008Humana Press eBooksRequires access

Sleep and Quality of Life in Sleep Apnea

Amy D. Atkeson, Robert C. Basner

Open publisher page 9 citations

Abstract

SummaryHealth-related quality of life (HRQOL) is increasingly recognized as an important parameter in the assessment of the morbidity associated with obstructive sleep apnea (OSA). Generic and sleep disorder-specific instruments consistently demonstrate impairment in multiple domains of HRQOL in OSA, particularly in the domains of sleep, energy, fatigue, and vigilance. Sleep disorder-specific tools are potentially more sensitive than generic tools in describing HRQOL impairment in untreated OSA and treatment effects of continuous positive airway pressure (CPAP) and are increasingly being employed in clinical trials of OSA treatment. Severe OSA is generally associated with severe HRQOL impairment; however, studies do not consistently demonstrate a linear relationship between physiologic measures of OSA severity and measures of severity of HRQOL impairment. Excessive sleepiness, cognitive dysfunction, and psychological impairment are common measurable components of HRQOL impairment in OSA, particularly severe OSA, but the interactions among these and quality of life impairments measured by standard HRQOL instruments are not well studied. Therapeutic CPAP appears to broadly improve HRQOL domains in OSA, but substantial placebo effect has been demonstrated, suggesting that HRQOL impairment in OSA may be mediated by aspects of the disorder other than the physiologic effects of the OSA. Further randomized controlled trials should better elucidate the associations between physiologic impairment in OSA and HRQOL measures of interest to clinicians and researchers in this field.

About this research paper

What this paper is about

SummaryHealth-related quality of life (HRQOL) is increasingly recognized as an important parameter in the assessment of the morbidity associated with obstructive sleep apnea (OSA). Generic and sleep disorder-specific instruments consistently demonstrate impairment in multiple domains of HRQOL in OSA, particularly in the domains of sleep, energy, fatigue, and vigilance. Sleep disorder-specific tools are potentially more sensitive than generic tools in describing HRQOL impairment in untreated OSA and treatment effects of continuous positive airway pressure (CPAP) and are increasingly being employed in clinical trials of OSA treatment. Severe OSA is generally associated with severe HRQOL impairment; however, studies do not consistently demonstrate a linear relationship between physiologic measures of OSA severity and measures of severity of HRQOL impairment. Excessive sleepiness, cognitive dysfunction, and psychological impairment are common measurable components of HRQOL impairment in OSA, particularly severe OSA, but the interactions among these and quality of life impairments measured by standard HRQOL instruments are not well studied. Therapeutic CPAP appears to broadly improve HRQOL domains in OSA, but substantial placebo effect has been demonstrated, suggesting that HRQOL impairment in OSA may be mediated by aspects of the disorder other than the physiologic effects of the OSA. Further randomized controlled trials should better elucidate the associations between physiologic impairment in OSA and HRQOL measures of interest to clinicians and researchers in this field.

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

SummaryHealth-related quality of life (HRQOL) is increasingly recognized as an important parameter in the assessment of the morbidity associated with obstructive sleep apnea (OSA). Generic and sleep disorder-specific instruments consistently demonstrate impairment in multiple domains of HRQOL in OSA, particularly in the domains of sleep, energy, fatigue, and vigilance. Sleep disorder-specific tools are potentially more sensitive than generic tools in describing HRQOL impairment in untreated OSA and treatment effects of continuous positive airway pressure (CPAP) and are increasingly being employed in clinical trials of OSA treatment. Severe OSA is generally associated with severe HRQOL impairment; however, studies do not consistently demonstrate a linear relationship between physiologic measures of OSA severity and measures of severity of HRQOL impairment. Excessive sleepiness, cognitive dysfunction, and psychological impairment are common measurable components of HRQOL impairment in OSA, particularly severe OSA, but the interactions among these and quality of life impairments measured by standard HRQOL instruments are not well studied. Therapeutic CPAP appears to broadly improve HRQOL domains in OSA, but substantial placebo effect has been demonstrated, suggesting that HRQOL impairment in OSA may be mediated by aspects of the disorder other than the physiologic effects of the OSA. Further randomized controlled trials should better elucidate the associations between physiologic impairment in OSA and HRQOL measures of interest to clinicians and researchers in this field.

Key concepts: Obstructive sleep apnea, Medicine, Continuous positive airway pressure, Quality of life (healthcare), Sleep disorder, Sleep apnea, Cognitive impairment, Placebo

Related papers

Back to paper searchBrowse research topicsOriginal source
Sleep and Quality of Life in Sleep Apnea — Research Paper | ScholarLens